{"id":207,"date":"2017-03-27T14:09:04","date_gmt":"2017-03-27T13:09:04","guid":{"rendered":"http:\/\/inmunologia.webs.uvigo.es\/?page_id=207"},"modified":"2018-06-13T16:48:09","modified_gmt":"2018-06-13T15:48:09","slug":"immunotherapy","status":"publish","type":"page","link":"https:\/\/inmunologia.webs9.uvigo.es\/?page_id=207","title":{"rendered":"Immunotherapy"},"content":{"rendered":"<p>Immunotherapy is the use of components of the <em><u>immune system<\/u><\/em> (antibodies, citokines, dendritic cells, etc.) in medicine, for the treatment of several illnesses such as cancer, allergy, autoimmune and infectious diseases. Immunotherapy also includes the use of vaccines in the prevention of infectious diseases or in the treatment of allergies or tumours. Immunotherapy may add new dimensions to the clinic, new ways of cure, with clear beneficial effects such as lower secondary effects, higher efficacy and better tolerance than other medicines.<\/p>\n<p>One research focus in our group is to generate innovative therapeutic agents. In this sense, we have obtained antigen specific fully human monoclonal antibodies (<strong>huMoAb<\/strong>) using genetically engineered mice and hybridoma technology.<\/p>\n<p>Particularly, we could highlight:<\/p>\n<ul>\n<li><strong>BH1<\/strong>, a huMoAb that recognizes the molecule HLA-class II.\u00a0 BH1\u00a0could be a good candidate as a therapeutic agent for the treatment of different <strong>HLA-class II positive leukaemias<\/strong> and other malignancies.<\/li>\n<li><strong>h-AIM29<\/strong>, this huMoAb is specific for the <strong>human CD69<\/strong> molecule. Some of its potential clinical application is for patients with <strong>arthritis<\/strong> or even with those with cancer.<\/li>\n<li>Several huMoAb directed to <strong>human B and monocytes cells<\/strong>.<\/li>\n<\/ul>\n<h3>Projects in this research line:<\/h3>\n\t\t\t\t<div class=\"jetpack-portfolio-shortcode column-4\">\n\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-nanomedicine type-projects type-vaccines portfolio-entry-mobile-first-item-row portfolio-entry-first-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t<a class=\"portfolio-featured-image\" href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=immunotherapy-in-pancreatic-cancer\"><img loading=\"lazy\" decoding=\"async\" width=\"829\" height=\"551\" src=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1-1024x681.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" srcset=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1-1024x681.jpg 1024w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1-300x200.jpg 300w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1-768x511.jpg 768w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1-480x320.jpg 480w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/01\/1C-R_1.jpg 1636w\" sizes=\"auto, (max-width: 829px) 100vw, 829px\" \/><\/a>\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=immunotherapy-in-pancreatic-cancer\" title=\"Immunotherapy in pancreatic cancer\">Immunotherapy in pancreatic cancer<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-contracts type-immunotherapy portfolio-entry-mobile-last-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t<a class=\"portfolio-featured-image\" href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=nueva-gama-de-ingredientes-y-alimentos-funcionales-para-un-envejecimiento-saludable\"><img loading=\"lazy\" decoding=\"async\" width=\"480\" height=\"320\" src=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" srcset=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320.jpg 480w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320-300x200.jpg 300w\" sizes=\"auto, (max-width: 480px) 100vw, 480px\" \/><\/a>\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=nueva-gama-de-ingredientes-y-alimentos-funcionales-para-un-envejecimiento-saludable\" title=\"Nueva gama de ingredientes y alimentos funcionales para un envejecimiento saludable (ENVELLEFUN)\">Nueva gama de ingredientes y alimentos funcionales para un envejecimiento saludable (ENVELLEFUN)<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-projects portfolio-entry-mobile-first-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t<a class=\"portfolio-featured-image\" href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=red-de-inmunoterapia\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"346\" src=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2018\/06\/Logo-Immunonet.gif\" class=\"attachment-large size-large wp-post-image\" alt=\"\" \/><\/a>\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=red-de-inmunoterapia\" title=\"Inmunotherapy Network (IMMUNONET)\">Inmunotherapy Network (IMMUNONET)<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-projects portfolio-entry-mobile-last-item-row portfolio-entry-last-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t<a class=\"portfolio-featured-image\" href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=mieloma-multiple-y-otras-gammapatias-de-la-genesis-a-la-terapeutica\"><img loading=\"lazy\" decoding=\"async\" width=\"480\" height=\"320\" src=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/virus-infected-cells-480_320.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" srcset=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/virus-infected-cells-480_320.jpg 480w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/virus-infected-cells-480_320-300x200.jpg 300w\" sizes=\"auto, (max-width: 480px) 100vw, 480px\" \/><\/a>\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=mieloma-multiple-y-otras-gammapatias-de-la-genesis-a-la-terapeutica\" title=\"Mieloma m\u00faltiple y otras gammapat\u00edas: de la g\u00e9nesis a la terap\u00e9utica\">Mieloma m\u00faltiple y otras gammapat\u00edas: de la g\u00e9nesis a la terap\u00e9utica<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-patents portfolio-entry-mobile-first-item-row portfolio-entry-first-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=human-monoclonal-antibody-recognizing-the-cd69-human-molecule\" title=\"Human monoclonal antibody recognizing the CD69 human molecule consists of a derivative of the hybridoma H69 obtained from myeloma and rat spleen cells\">Human monoclonal antibody recognizing the CD69 human molecule consists of a derivative of the hybridoma H69 obtained from myeloma and rat spleen cells<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-patents portfolio-entry-mobile-last-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=anticuerpo-monoclonal-humano-sm5020-que-reconoce-leucocitos-humanos-y-su-uso-en-terapia\" title=\"SM 50\/20 human monoclonal antibody consists of hybridoma obtained from immunized mice and recognising human leucocytes\">SM 50\/20 human monoclonal antibody consists of hybridoma obtained from immunized mice and recognising human leucocytes<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t\t<div class=\"portfolio-entry portfolio-entry-column-4 type-immunotherapy type-projects portfolio-entry-mobile-first-item-row\">\n\t\t\t\t\t\t<header class=\"portfolio-entry-header\">\n\t\t\t\t\t\t<a class=\"portfolio-featured-image\" href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=feder-1fd-1997-2313-c02-02\"><img loading=\"lazy\" decoding=\"async\" width=\"480\" height=\"320\" src=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" srcset=\"https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320.jpg 480w, https:\/\/inmunologia.webs9.uvigo.es\/wp-content\/uploads\/2017\/03\/analysis_480_320-300x200.jpg 300w\" sizes=\"auto, (max-width: 480px) 100vw, 480px\" \/><\/a>\n\t\t\t\t\t\t<h2 class=\"portfolio-entry-title\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=feder-1fd-1997-2313-c02-02\" title=\"Uso de panel de anticuerpos monoclonales humanos para el tratamiento de leucemias y linfomas humanos\">Uso de panel de anticuerpos monoclonales humanos para el tratamiento de leucemias y linfomas humanos<\/a><\/h2>\n\n\t\t\t\t\t\t\t<div class=\"portfolio-entry-meta\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t<\/header>\n\n\t\t\t\t\t\t\t\t\t\t<\/div><!-- close .portfolio-entry -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- close .jetpack-portfolio -->\n\t\t\t\t\n","protected":false},"excerpt":{"rendered":"<p>One research focus in our group is to generate innovative therapeutic agents. <span class=\"readmore\"><a href=\"https:\/\/inmunologia.webs9.uvigo.es\/?portfolio=feder-1fd-1997-2313-c02-02\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":1399,"parent":194,"menu_order":50,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-207","page","type-page","status-publish","has-post-thumbnail","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=207"}],"version-history":[{"count":16,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/207\/revisions"}],"predecessor-version":[{"id":1427,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/207\/revisions\/1427"}],"up":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/pages\/194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=\/wp\/v2\/media\/1399"}],"wp:attachment":[{"href":"https:\/\/inmunologia.webs9.uvigo.es\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}